WAUKESHA, WI – September 7, 2016 – Today, GE Healthcare (NYSE: GE) is proud to announce that MAGiC (MAGnetic resonance image Compilation), the industry’s first multi-contrast magnetic resonance (MR) technique, is now 510(k) cleared by the U.S. FDA*. MAGiC, the result of a collaboration with SyntheticMR AB, gives clinicians more data than conventional scanning in a fraction of the time.

TUSTIN, Calif., Sept. 7, 2016 – To show the benefits of the recent FDA approval of ultrasound contrast for characterizing liver lesions in adults and pediatrics, Toshiba America Medical Systems, Inc.’s AplioTM 500 Platinum ultrasound system, with its comprehensive contrast imaging package, will be used during a live case following the International Contrast Ultrasound Society (ICUS) Bubbles Conference, September 8–9, 2016, in Chicago.

ROCHESTER, N.Y., Aug. 31 — Carestream is shipping its new DRX Core family of DRX detectors designed to make reliable, high-quality DR imaging affordable for imaging centers, small to mid-size hospitals, urgent care facilities, specialty clinics and providers that perform mobile imaging exams.

Siemens Healthineers has announced that the Food and Drug Administration (FDA) has cleared the SOMATOM Drive computed tomography (CT) system. This new dual source scanner is designed to drive precision in diagnostic imaging across a wide range of clinical disciplines – from pediatrics and emergency medicine to cardiology and oncology – as well as deliver a new level of quality in patient with the potential to reduce examination time, preparation, and follow-up care.

The European College of Cardiology compared non-invasive coronary artery procedures to determine which approach is best. 

ROCHESTER, N.Y., Aug. 23 — Franciscan Health Rensselaer (Rensselaer, Ind.) purchased a new CARESTREAM DRX-Excel Plus radiography/fluoroscopy (R/F) system and a CARESTREAM DRX-Evolution Plus to deliver rapid access to high-quality X-ray images that help physicians assess and treat patients at this critical access hospital.

After reviewing the available literature, the societies said that rest-stress myocardial perfusion PET was a first-line preferred test for patients with known or suspected coronary artery disease who meet the criteria for stress imaging and are unable to complete the diagnostic level exercise stress imaging study.

As we continue to move closer to the 2016 presidential election, it seems like opponents of both parties are getting meaner and nastier. With that hate-filled climate in mind, I wanted to applaud the Medical Imaging & Technology Alliance (MITA) for handing out several “2016 Innovation Awards” this summer to politicians who have made a positive impact on the medical imaging industry.